Johannes Gambari, PhD
Johannes Gambari, PhD is a Senior Analyst at CBPartners, working across a variety of practices to address a range of commercial business issues.
CHN’s NRDL Update – Worth the Wait (and Heavy Discounting)?
15 March 2017
Convergence Between KOR and TWN HTA Decisions, Could Major Political Events be Responsible for Diverging Decisions?
1 September 2016
Could STIVARGA Court Ruling Change the Meaning of Class Cnn Reimbursement in Italy?
2 October 2015
WHITE PAPER: The CEESP Economic Evaluation: Can Clinical Efficacy and Cost-effectiveness Co-exist in France?
7 July 2015
Poster at ISPOR international on the role of indirect comparisons in the AMNOG evaluation procedure
18 May 2015
No sweet deals for TOUJEO
27 April 2015
Opportunities and Challenges in Emerging Markets
14 April 2015